Organ transplantation, a life-saving medical marvel, presents profound ethical dilemmas.  The scarcity of donor organs necessitates difficult allocation decisions, akin to distributing a limited number of lifeboats amongst numerous shipwrecked passengers.  Utilitarian approaches, prioritizing the greatest good for the greatest number, might favor individuals with higher survival probabilities, resembling triage in disaster scenarios.  However, this raises concerns about inherent biases and potential discrimination against specific patient populations, akin to unfairly weighting certain lifeboat candidates.  Furthermore, the concept of informed consent is complex, especially concerning deceased donation where surrogate decision-making is required, echoing challenges in determining the best interests of incapacitated individuals.  The commercialization of organs, a modern-day "body parts market," introduces exploitation and exacerbates inequalities, resembling a flawed economic system where access to essential resources is determined by wealth rather than need.  Addressing these ethical challenges requires robust regulatory frameworks, transparent allocation systems, and ongoing public discourse to ensure equitable access to life-saving transplants while upholding fundamental human rights and dignity.